Factor Bioscience
Cambridge
About Factor Bioscience
Factor Bioscience is building the future of regenerative medicine by targeting and repairing the molecular origins of disease. Factor Bioscience was established to explore new methods for controlling gene expression and cell fate. Their scientists developed the fastest, highest-efficiency method for reprogramming somatic cells to a pluripotent stem-cell state, a key invention now recognized by several patents. This technology, which enables the production of patient-specific cells for transplantation, has wide-ranging applications in personalized regenerative medicine.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Last round: Grant (Jan 2024)
- Website: factorbio.com
- Phone: 781.640.1031
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/factor-bioscience-2229726 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.